Omega Protein


Omega Protein Reports $5.8 Million Profit For 2003

HOUSTON, February 27, 2004 - Omega Protein Corporation (NYSE symbol: OME), the world's largest manufacturer of heart-healthy fish oils containing long-chain Omega-3 fatty acids, today reported net income for the 2003 fiscal year of $5.8 million, or 24 cents per share, compared with net income of $12.2 million, or 51 cents a share, the previous year.

Omega Protein recorded revenues of $117.9 million for the 2003 fiscal year which ended December 31, compared with revenues of $117.0 million for 2002. Operating income for 2003 was $9.4 million, versus operating income of $18.7 million for the prior year.

For the fourth quarter of 2003, the Company recorded net income of $31,000, compared with net income of $2.9 million the previous year. Revenues for the quarter which ended December 31, 2003 were $33.4 million, versus revenues of $31.3 million for the corresponding 2002 quarter. Omega Protein had an operating loss of $73,000 for the 2003 fourth quarter, compared with operating income of $3.7 million for the 2002 fourth quarter.

Omega Protein's fourth quarter results, as well as the results for the full year, reflect a lower than expected fish catch (approximately 11% below both 2003 expectations and 2002 fish catch level), combined with low oil yields. The reduced fish catch was primarily attributable to adverse weather conditions along the Atlantic Coast and the Gulf of Mexico and the low oil yields were due to reduced fat content of the fish. The reduced fish catch and low oil yields resulted in higher per unit cost inventories, as well as less product available for sale.

While 2003 was not as strong a year as we hoped it would be, the Company still performed well, said Joe von Rosenberg, President and Chief Executive Officer. AFurthermore, we are optimistic about our prospects for 2004 due to increasing consumer and food company awareness about the health benefits of long-chain Omega-3's.


Omega Protein Corporation is the nation's largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.


Special Note Regarding Forward-Looking Statements: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward -looking statements include, among others, (1) the Company's ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, adverse weather conditions and disease; (2) the impact of worldwide supply and demand relationships on prices for the Company's products; and (3) fluctuations in the Company's quarterly operating results due to the seasonality of the Company's business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its 2002 Annual Report on Form 10K under the headings, Management's Discussion and Analysis of Financial Condition and Results of Operations Significant Factors That May Affect Forward-Looking Statements and Seasonality and Quarterly Results.

Contact: Investor Relations Department (713) 623-0060 or news@omegahouston.com


OMEGA PROTEIN CORPORATION
Statement of Operations
(Unaudited)
 
  Three Months
Ended December 31,
Twelve Months
Ended December 31,
  2003 2002 2003 2002
  (in thousands, except per share amounts)
Revenues $33,382 $31,300 $117,926 $117,008
Cost of sales 30,682 24,971 99,028 89,305
Gross profit 2,700 6,509 18,898 27,703
Selling, general, and
administrative expense
2,773 2,782 9,484 9,040
Operating income (loss) (73) 3,727 9,414 18,663
Interest income (expense), net (194) (121) (691) (595)
Other (expense), net (77) (61) (119) (222)
Income before income taxes (344) 3,545 8,604 17,846
Provision for income taxes (375) 626 2,806 5,677
Net income $31 $2,919 $5,798 $12,169
Basic earnings per share $0.00 $0.13 $0.24 $0.51
Average common shares outstanding 24,382 23,970 24,193 23,962
Earnings per shares (diluted) $0.00 $0.11 $0.22 $0.48
Average common shares and
common share equivalents outstanding
26,149 25,201 25,807 25,106





OMEGA PROTEIN CORPORATION CONDENSED BALANCE SHEET (Unaudited)

  December 31, 2003 December  31, 2002
  (in thousands, except per share amounts)
ASSETS    
Current assets $97,445 $90,620
Property and equipment, net 85,231 80,713
Deferred tax assets, net 405 3,115
Other assets 3,087 4,507
   Total Assets $186,618 $179,027
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities $16,508 $18,769
Long-term debt, less current maturities 17,605 14,239
Other long-term liabilities 6,838 10,983
Stockhoders' equity 145,217 135,036
   Total liabilities and stockholders' equity $186,168 $179,027
   BOOK VALUE PER SHARE OUTSTANDING $6.00 $5.63
  Omega Protein Corporation, Inc. All rights reserved.